Use of Fractional Laser in Mixed-Race Patients

Abstract

The use of fractional lasers in mixed race patients has always been a challenge. Post-inflammatory hyperpigmentation or worsening of existing melasma is a risk and its presence can be unpredictable. The authors present their experience in patients with Fitzpatrick skin types IV to VI using fractional lasers. Pre- and post-laser regimens to avoid complications are presented and results are evaluated.

Keywords

mixed race - fractional laser - CO₂ laser - erbium 1 - 550 nm - melasma - postinflammatory hyperpigmentation

• References

• 1 Bhatt N, Alster TS. Laser surgery in dark skin. Dermatol Surg 2008; 34: 184-194 , discussion 194–195
• 2 Rahman Z, Alam M, Dover JS. Fractional laser treatment for pigmentation and texture improvement. Skin Therapy Lett 2006; 11: 7-11
• 3 Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg 2005; 31: 1645-1650
• 4 Wind BS, Kroon MW, Meesters AA , et al. Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study. Lasers Surg Med 2010; 42: 607-612
• 5 Ancona D, Katz BE. A prospective study of the improvement in periorbital wrinkles and eyebrow elevation with a novel fractional CO2 laser—the fractional eyelift. J Drugs Dermatol 2010; 9: 16-21
• 6 Gold M. AcuPulse TM with combo treatment modality: clinical study of patients with skin of color. Gold Skin Care Center and Tennessee Clinical Research Center Inc. 2012; 1–3. Available at: http://www.hv.com.br/Medical/Artigos/WHITE_PAPER_AcuPulse_Gold_A4_EXAMPLE.pdf . Accessed June 1, 2012
• 7 Avram MM, Tope WD, Yu T, Szachowicz E, Nelson JS. Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacing. Lasers Surg Med 2009; 41: 185-188
• 8 Cassuto DA, Sadick NS, Scrimali L, Siragò P. An innovative device for fractional CO2 laser resurfacing: a preliminary clinical study. The American Journal of Cosmetic Surgery 2008; 25 (2) 97-101
• 9 Goh CL. Lasers and light devices in the treatment of cosmetic pigmentary disorders in Asian skin. Dermatol Nurs 2010; 22: 17-24
• 10 Wasserman DI, Chuang GS. Update on cutaneous laser therapy:Recent medical advances of laser light and skin interactions. Expert Rev Dermatol 2011; 6 (2) 163-174
• 11 Stotland M, Chapas AM, Brightman L , et al. The safety and efficacy of fractional photothermolysis for the correction of striae distensae. J Drugs Dermatol 2008; 7: 857-861
• 12 Reddy UP, Woodward JA. Ablative fractionated CO2 laser resurfacing for the face and neck. The American Journal of Cosmetic Surgery 2011; 28 (4) 273-275
• 13 Kim H, Choi HR, Kim DS, Park KC. Topical hypopigmenting agents for pigmentary disorders and their mechanisms of action. Ann Dermatol 2012; 24: 1-6
• 14 Cayce KA, McMichael AJ, Feldman SR. Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs 2004; 16: 401-406 , 413–416, quiz 417
• 15 Lynde CB, Kraft JN, Lynde CW. Topical treatments for melasma and postinflammatory hyperpigmentation. Skin Therapy Lett 2006; 11: 1-6
• 16 Davis EC, Callender VD. Post inflammatory hyperpigmentation, a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol 2010; 3 (7) 20-31
• 17 Halder RM, Richards GM. Topical agents used in the management of hyperpigmentation. Skin Therapy Lett 2004; 9: 1-3
• 18 Manuskiatti W, Eimpunth S, Wanitphakdeedecha R. Effect of cold air cooling on the incidence of postinflammatory hyperpigmentation after Q-switched Nd:YAG laser treatment of acquired bilateral nevus of Ota like macules. Arch Dermatol 2007; 143: 1139-1143